DENVER–(BUSINESS WIRE)–Clear Cannabis, Inc. (CCI), a leading cannabis distribution and infrastructure company in legal marijuana states, announced it is opening a $10 million, private funding round for accredited investors on the website www.flashfunders.com/clear.
“With support from our current investors, we believe we were able to elevate The Clear™ Concentrates brand to one of the most recognizable brands in cannabis,” said John Cushman, CEO for Clear Cannabis, Inc. “Opening funding gives us the opportunity to continue to grow industry-leading cannabis brands into existing and emerging legal cannabis markets. Along with our manufacturing partners, we are committed to providing adult cannabis consumers with a consistent and clean product.”
Colorado-based, CCI owns the intellectual property of pioneering cannabis concentrate brand, The Clear™ and licenses the brand out to partners in different states to produce the product. CCI provides licensed partners with the infrastructure and branding to consistently produce the entire product suite of The Clear. CCI is also launching an expanded CBD line of products, growing its hemp product offerings in the last year. The Clear CBD new products expect to include AM capsules, PM capsules, lip balm, tinctures and salves.
According to BDS Analytics, concentrates are expected to be an $8 billion retail market by 2022, outpacing the expected sales of traditional flower.
CCI has increased the visibility and reach of The Clear Concentrates. After originally starting in California in 2014 as the gold standard of cannabis extract, CCI has acquired and grown the brand to be widely available in six states in the U.S.
Past performance is not indicative of future results. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of loss.
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.
About Clear Cannabis, Inc.
Clear Cannabis, Inc. is the international master licensor of “The Clear Concentrate” and the Clear family of products. The Clear was created as a consolidation from Cannabis Venture Capital firm Cliintel Capital Management Group, LLC. The consolidation included the portfolios of seven cannabis-related companies and corresponding intellectual property assets: The Clear™ Concentrates, Subtle Escape, Subtle Relief, 5156 Systems, Cannabis Industry Institute, Cliintel, LLC, and BATMANN Consulting, Inc.